🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Weerawat Manosuthi

Ministry of Public Health

ORCID: 0000-0003-2583-9390

Also affiliated with Department of Disease Control, Bamrasnaradura Infectious Diseases Institute

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 4 papers. Top paper: “Urine-Xpert Ultra for the diagnosis of tuberculosis in people living with HIV: a prospective, multicentre, diagnostic accuracy study”.

Urine-Xpert Ultra for the diagnosis of tuberculosis in people living with HIV: a prospective, multicentre, diagnostic accuracy study

The Lancet Global Health(2024)10.1016/s2214-109x(24)00357-7
N/A
0.540DataRank · unranked
15 citations

Rita Székely, Madalo Mukoka, Monde Muyoyeta, Elizabeth Nakabugo, Jerry Hella +43 more

Dosage Optimization of Efavirenz Based on a Population Pharmacokinetic–Pharmacogenetic Model of HIV-infected Patients in Thailand

Clinical Therapeutics(2020)10.1016/j.clinthera.2020.04.013
N/A
0.347DataRank · unranked
5 citations

Anchalee Avihingsanon, Weerawat Manosuthi, Sasiwimol Ubolyam, Siraprapa Tongkobpetch, Vorasuk Shotelersuk +2 more

A Randomized Trial to Compare Dolutegravir Plus Boosted Darunavir Versus Recommended Standard of Care Antiretroviral Regimens in People With HIV-1, Whose First-line Non-nucleoside Reverse Transcriptase Inhibitor Therapy Has Failed: Final 96-week Results of the D2EFT Study

Clinical Infectious Diseases(2025)10.1093/cid/ciaf346
N/A
0.165DataRank · unranked
2 citations

Margaret Borok, Nnakelu Eriobu, Richard Kaplan, Nagalingeswaran Kumarasamy, Anchalee Avihingsanon +44 more

Early Treatment of Favipiravir in COVID-19 Patients Without Pneumonia: A Multicentre, Open-Labelled, Randomized Control Study

medRxiv(2022)10.1101/2022.06.06.22275902
N/A
0DataRank · unranked
5 citations

Weerawat Manosuthi, Suvimol Niyomnaitham, Andrew Owen, Katherine Copeland, Lantharita Charoenpong +4 more